tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (SE:ELIC)
:ELIC

Elicera Therapeutics AB (ELIC) Revenue

Compare
3 Followers

Elicera Therapeutics AB Revenue

Elicera Therapeutics AB had a revenue of 0.00 in the quarter ending Sep 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 5.79M, Increased -3.88%. In the fiscal year ending Dec 31, 2024, Elicera Therapeutics AB had annual revenue of 7.13M with -36.53% growth.
Revenue (ttm)
5.79M
Revenue Growth
P/S Ratio
37.99
Revenue/Employee
kr3,564,000
Employees
2
Market Cap
kr270.83M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.13M-4.10M+63.47%
Dec 31, 2023
11.23M9.95M+877.34%
Dec 31, 2022
1.28M1.28M+218,430.03%
Dec 31, 2021
587.00-58,700.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016